Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Sep 20;41(27):4338-4340.
doi: 10.1200/JCO.23.00284. Epub 2023 Aug 9.

On Cancer Screening During the COVID-19 Pandemic

Otis W Brawley  1
Affiliations
Editorial

On Cancer Screening During the COVID-19 Pandemic

Otis W Brawley. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Otis W. Brawley

Leadership: PDS Biotechnology, Incyte, Agilent, Lyell Immunopharma, Jackson Laboratory for Genomic Medicine

Honoraria: Genentech/Roche (less than $5,000 USD in a single calendar year), Grail ($5,000 USD or above in a single calendar year)

Consulting or Advisory Role: Genentech/Roche ($5,000 USD or above in a single calendar year), Grail ($5,000 USD or above in a single calendar year)

Travel, Accommodations, Expenses: Genentech/Roche

No other potential conflicts of interest were reported.

Figures

FIG 1.
FIG 1.
(A) The number of breast, cervical, and prostate cancer screening tests performed in 2021 was less than that in 2019. (B) The proportional decline in screening for breast, cervical, and prostate cancer comparing 2019 screening rates with 2021 screening rates.
See this image and copyright information in PMC

Comment on

References

    1. CDC COVID Data Tracker, 2023. https://covid.cdc.gov/covid-data-tracker/#datatracker-home
    1. Sharpless NE: COVID-19 and cancer. Science 368:1290, 2020 - PubMed
    1. Star J, Bandi P, Siegel RL, et al. : Cancer screening in the United States during the second year of the COVID-19 pandemic. J Clin Oncol 41:4352-4359, 2023 - PMC - PubMed
    1. National Center for Health Statistics : National Health Interview Survey, 2019 and 2021. Hyattsville, MD, 2022
    1. Limburg PJ: As screening declines amid COVID-19, at-home stool DNA test for CRC gets high adherence in Medicare population. Washington, DC, The Cancer Letter. Paul Goldberg, 2020